United Therapeutics’ (UTHR) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $425.00 price objective on the biotechnology company’s stock. A number of other brokerages have also issued reports on UTHR. LADENBURG THALM/SH SH raised their price target on […]
HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $425.00 price objective on the biotechnology company’s stock. A number of other brokerages have also issued reports on UTHR. LADENBURG THALM/SH SH raised their price target on […]
